Transdermal drug delivery system with improved water absorbability and adhesion properties
A drug delivery system and adhesive technology, applied in the field of release liner, which can solve the problems of poor adhesion and poor dissolution of acrylic adhesives
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1-17 and comparative Embodiment 1
[0057] The transdermal drug delivery system was prepared according to the following method, and the composition of the matrix layer (2) is shown in Table 1-3.
[0058] Diclofenac diethylammonium salt, polyvinylpyrrolidone (Povidone 90F, Povidone 25K), colloidal silicon dioxide (Aerosil 380, 200, Degussa Company) were added to a 50 ml sample bottle. After adding the nonionic surfactant and ethanol, stir at 40°C until the pharmaceutical composition is completely dissolved. The mixture solution was cooled to room temperature, and an acrylate adhesive (National Starch & Chemical Company, Durotak TM , 87-2852, 87-2196, 87-4098). The resulting solution was stirred to mix all components in the vial and allowed to stand for 20 minutes to remove air bubbles. Then, with a laboratory coater and drier (Mathis company, Switzerland), the mixture is poured onto the backing film (1) and the release liner (3) to form adhesive layers (2a') and (2a " ), and dried at 80-120°C for 10 minutes. ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
| molecular weight | aaaaa | aaaaa |
| thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 